{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:53:00Z","timestamp":1773211980653,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p>\n            <jats:italic>Background and Purpose<\/jats:italic>\n            The association of cerebral venous thrombosis (CVT) with a variety of pathological states is well established. However, there are only rare isolated reports of CVT associated with anticardiolipin antibodies (aCL).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods<\/jats:italic>\n            To clarify the clinical and neuradiological features as well as outcome of patients with CVT associated with aCL, we reviewed the records of all patients with CVT evaluated at our institution between 1989 and 1996 (retrospective and prospective) and systematically reviewed the pertinent literature.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Results<\/jats:italic>\n            We identified 8 aCL+ and 7 aCL\u2212 patients with CVT. No patients with lupus anticoagulant (LA) were identified. The mean age was 23\u00b111.01 (range, &lt;1 to 36) years in the aCL+ and 38\u00b19.30 (range, 25 to 54) years in the aCL\u2212 patients (\n            <jats:italic>P<\/jats:italic>\n            =.016). Six of 8 aCL+ and 5 of 7 aCL\u2212 patients were women. The dural sinuses were involved in all aCL+ and in 6 of 7 aCL\u2212 patients, while deep venous system thrombosis occurred in 5 of 8 (63%) aCL+ and 1 of 7 (14%) aCL\u2212 patients. In the aCL+ patients CVT was associated with puerperium or oral contraceptive use (n=6) and sickle cell trait (n=1), and in the aCL\u2212 patients CVT was associated with systemic lupus erythematosus (n=1), myelodysplastic syndrome (n=1), colonic cancer (n=1), oral contraceptive use or puerperium (n=3), and dehydration (n=1). Seven aCL+ patients received either intrasinus urokinase or intravenous heparin sulfate, and 1 received aspirin. Four aCL+ patients developed new onset or worsening of preexisting migraine, 2 developed recurrent peripheral venous thrombosis, and 1 went on to have intracranial hypertension. Twenty additional patients with CVT associated with antiphospholipid antibodies (aPL) were found reported in the literature. The overall mean age was 36\u00b111.6 (range, 21 to 62) years, and 14 (70%) were women. LA was present in 11 of 18 tested, aCL in 7 (35%), LA and aCL in 1, and the type of aPL was not reported in 3. The mean age for the aCL+ only group was 28 years and for the LA+ (with or without aCL+) was 34 years. Only 1 patient, whose aPL type was not specified, had thrombosis of the deep venous system in addition to involvement of the dural sinuses.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            Our series and review suggest that aCL may be an important factor contributing to development of CVT even in the presence of other potential etiologies or risk factors. Onset of aCL+ CVT occurs at a relative young age and with relatively more extensive superficial and deep cerebral venous system involvement than aCL\u2212 CVT.\n          <\/jats:p>","DOI":"10.1161\/01.str.28.12.2363","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:08:03Z","timestamp":1308341283000},"page":"2363-2369","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":81,"title":["Cerebral Venous Thrombosis and Anticardiolipin Antibodies"],"prefix":"10.1161","volume":"28","author":[{"given":"Juan R.","family":"Carhuapoma","sequence":"first","affiliation":[{"name":"From the Center for Stroke Research, Department of Neurology and Henry Ford Stroke Program, Henry Ford Hospital and Health Sciences Center, Detroit, Mich (Detroit Campus of Case Western Reserve University)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis","family":"Mitsias","sequence":"additional","affiliation":[{"name":"From the Center for Stroke Research, Department of Neurology and Henry Ford Stroke Program, Henry Ford Hospital and Health Sciences Center, Detroit, Mich (Detroit Campus of Case Western Reserve University)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Levine","sequence":"additional","affiliation":[{"name":"From the Center for Stroke Research, Department of Neurology and Henry Ford Stroke Program, Henry Ford Hospital and Health Sciences Center, Detroit, Mich (Detroit Campus of Case Western Reserve University)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"1778","volume":"19","year":"1992","unstructured":"Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome. J Rheumatol. 1992;19:1778\u20131781.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.21.9.2396261"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)30237-8"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Feldmann E Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms significance and therapeutic options. Ann Neurol. 1995;37(suppl 1):S114\u2013S130.","DOI":"10.1002\/ana.410370712"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1041075"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-9-682"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.16.2.3975957"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.27.2.243"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.25.1.8266378"},{"key":"e_1_3_2_10_2","first-page":"1021","volume":"16","year":"1995","unstructured":"Tsai FY, Wang AM, Matovich VB, Lavin M, Berberian B, Simonson TM, Yuh WTC. MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol. 1995;16:1021\u20131029.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.162.5.8166009"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.27.10.1721"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.27.10.1724"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.27.10.1731"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)30235-4"},{"key":"e_1_3_2_16_2","unstructured":"Bousser MG Barnett HJM. Cerebral venous thrombosis. In: Barnett HJM Mohr JP Stein BM Yatsu FM eds. Stroke: Pathophysiology Diagnosis and Management. New York NY: Churchill Livingstone Inc; 1992:517\u2013537."},{"key":"e_1_3_2_17_2","unstructured":"Lefkowitz D. Cortical thrombophlebitis and sinusvenous disease. In: Vinken PJ Bruyn GW Klawans HL Toole JP. Handbook of Clinical Neurology. New York NY: Elsevier Science Publishers BV; 1989:395\u2013423."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.21.8.2389304"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.18.4.3111017"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199409000-00007"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.24.3.8446985"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb138408.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.71.838.487"},{"key":"e_1_3_2_24_2","unstructured":"Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1\u201396."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.46.1.1"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/94.4.476"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.V68.2.472.472","volume":"68","year":"1986","unstructured":"Rosove MH, Ismail M, Koziol BJ, Runge A, Kasper CK. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain antiphospholipid in standard and high concentrations. Blood. 1986;68:472\u2013478.","journal-title":"Blood"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V68.4.869.869","volume":"68","year":"1986","unstructured":"Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood. 1986;68:869\u2013874.","journal-title":"Blood"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90262-3"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.853.690"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(199605)52:1<69::AID-AJH2830520105>3.0.CO;2-O"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1031.1031"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650289"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90286-0"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0308-2261(18)30023-7","volume":"15","year":"1986","unstructured":"Vermylen J, Blockmans D, Spitz B, Deckmyn H. Thrombosis and immune disorders. Clin Haematol. 1986;15:393\u2013412.","journal-title":"Clin Haematol"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540350095021"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380112"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90607-Q"},{"key":"e_1_3_2_39_2","first-page":"412","volume":"90","year":"1994","unstructured":"Al-Din N, Mubaidin A, Wriekat AL, Alqam, M. Risk factors of aseptic intracranial venous occlusive disease. Acta Neurol Scand. 1994;90:412\u2013416.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80698-9"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.26.7.1193"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.28.12.2363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:18:09Z","timestamp":1715552289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.28.12.2363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1161\/01.STR.28.12.2363"],"URL":"https:\/\/doi.org\/10.1161\/01.str.28.12.2363","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]},"assertion":[{"value":"1997-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-09-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}